Cutaneous responses to vaccinia in individuals with previous smallpox vaccination

Journal of the American Academy of Dermatology

Volumn 57, Issue 3, 2007, Pages 442-444

  Simpson, Eric L ^a   Hercher, Michelle ^b   Hammarlund, Erika K ^c   Lewis, Matthew W ^c   Slifka, Mark K ^c   Hanifin, Jon M ^a  

^a Department of Dermatology ^*  (United States)

^b University School of Medicine   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SMALLPOX VACCINE; VACCINIA ANTIBODY;

ADULT; ANTIBODY RESPONSE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; HUMAN; IMMUNE RESPONSE; INFECTION SENSITIVITY; LONG TERM CARE; PHOTOGRAPHY; PRIORITY JOURNAL; SKIN MANIFESTATION; SKIN SENSITIVITY; SMALLPOX; STATISTICAL SIGNIFICANCE; VACCINATION REACTION; VACCINIA;

EID: 34547828747     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2007.04.022     Document Type: Article

References (11)

1. Kaplan E., Craft D., and Wein L. Emergency response to a smallpox attack: the case for mass vaccination. Proc Natl Acad Sci U S A 99 (2002) 10935-10940
2. Hammarlund E., Lewis M.W., Hansen S.G., Strelow L.I., Nelson J.A., Sexton G.J., et al. Duration of antiviral immunity after smallpox vaccination. Nat Med 9 (2003) 1131-1137
3. Frey S., Newman F.K., Yan L., and Belshe R.B. Response to smallpox vaccine in persons immunized in the distant past. J Am Med Assoc 289 (2003) 3295-3299
4. Putz M.M., Alberini I., Midgley C.M., Manini I., Montomoli E., and Smith G.L. Prevalence of antibodies to vaccinia virus after smallpox vaccination in Italy. J Gen Virol 86 (2005) 2955-2960
5. Nishiura H., and Eichner M. Estimation of the duration of vaccine-induced residual protection against severe and fatal smallpox based on secondary vaccination failure. Infection 34 (2006) 241-246
6. Crotty S., Felgner P., Davies H., Glidewell J., Villarreal L., and Ahmed R. Cutting edge: long-term B cell memory in humans after smallpox vaccination. J Immunol 171 (2003) 4969-4973
7. Cohen J. Bioterrosism. Smallpox vaccinations: how much protection remains?. Science 294 (2001) 500
8. Tom W., Kenner J., and Friedlander S. Smallpox: vaccine reactions and contraindications. Derm Clin 22 (2004) 275-289
9. Kim S.-H., Yeo S.-G., Jang H.-C., Park W.-B., Lee C.-S., Lee K.-D., et al. Clinical responses to smallpox vaccine in vaccinia-naïve and previously vaccinated populations: undiluted and diluted lancy-vaxina vaccine in a single-blind, randomized, prospective trial. J Infect Dis 192 (2005) 1066-1070
10. Kim S.-H., Bang J.-W., Park K.-H., Park W.-B., Kim H.-B., Kim N.-J., et al. Prediction of residual immunity to smallpox, by means of an intradermal skin test with inactivated vaccinia virus. J Infect Dis 194 (2006) 377-384
11. Amanna I., Slifka M., and Crotty S. Immunity and immunological memory following smallpox vaccination. Immunol Rev 211 (2006) 320-327